Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Biomarkers in clinical trials of Alzheimer Disease (AD): What is expected from regulatory agencies?
Publication date
01-04-2009
Published in
The journal of nutrition, health & aging / Issue 4/2009
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-009-0035-8

Other articles of this Issue 4/2009

The journal of nutrition, health & aging 4/2009 Go to the issue

Structural Imaging Markers for Therapeutic Trials in Alzheimer’s Disease

Structural imaging markers for therapeutic trials in Alzheimer’s disease

JNHA: Clinical Neurosciences

The association of thyroid stimulating hormone levels with cognitive function and depressed mood: The Rancho Bernardo study

JNHA: Clinical Trials and Aging

How can we recognize “disease modification” effects?

Use of Biomarkers to Select the Target Population for Clinical Trials

Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment

The Validity of Biomarkers as Surrogate Endpoints in Alzheimer’s Disease

The validity of biomarkers as surrogate endpoints in Alzheimer’s disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)

Awareness of Weight and Height

Unawareness of weight and height - the effect on self-reported prevalence of overweight in a population-based study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits